Panic disorder. Panic disorder [episodic paroxysmal anxiety] without agoraphobia
Conditions
Interventions
Intervention 1: Intervention group: The participants (30 women) will receive propranolol (Propranolol hydrochloride tablet oral 10 mg) with the trade name (Pranol®) at a dose of 10-20 mg plus sertrali
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Women Women with researcher-diagnosed panic disorder (psychiatrist) based on diagnosis criteria (DSM-IV) Sufficient literacy to complete the questionnaire or accompany a literate person in the family
Exclusion criteria
Exclusion criteria: Abuse of tobacco and alcohol The occurrence of a stressful event (such as divorce, death of a first-degree family member, diagnosis of a terminal or incurable disease for a family member within the last three months, and job loss) Systemic disorders (such as cardiovascular, diabetes, asthma, digestive, liver, blood, endocrine) Taking antidepressants (such as antihistamines, barbiturates, narcotics, diazepam, amphetamines, and cocaine)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Panic attack. Timepoint: At the beginning of the study and 4 weeks after the start of consumption. Method of measurement: Panic Disorder Severity Scale – Self Report Form (PDSS-SR). | — |
Secondary
| Measure | Time frame |
|---|---|
| Depression score. Timepoint: At the beginning of the study and 4 weeks after the start of consumption. Method of measurement: Beck Depression Inventory short form. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSepideh Mashayekh Amiri
Tabriz University of Medical Sciences
Outcome results
None listed